Copy
ESCI Newsletter - Number 35 - Juli 2020 


Dear ESCI Members,
dear Friends, dear Colleagues


We are still in the middle of a one-in-a-lifetime event, a pandemic outbreak which has changed all our lives, affecting billions worldwide.

As the death toll approaches 600K people worldwide, one must consider why were we not better prepared for this type of outbreaks. We all believe it was coming someday, but our decision makers did not care for that. Moreover, it seems that instead of learning to play ball together, the political world has decided to play different games, with different rules (or with no rules). Fortunately, the medical and scientific world has decided to do otherwise, and different joint initiatives have been mounted to search for an effective treatment and vaccine for covid-19. As scientists, we must join to achieve objectives for the collective good. We cannot forget one main lesson from covid-19: together, we can reach higher. Fierce competition and dubious strategies to be the first one to publish data is a less effective strategy for the common good. One must not forget that covid-19 is not the only challenge the scientific world faces. We must build larger and better consortia so that we van understand and treat different human pathologies, uniting fundamental investigation with clinical practice. The often said (but rarely used) expression, “from the bench to the bed side” must resonate now more than never. This is a key mission of the European Society for Clinical Investigation, your Society, and we should all work together towards that objective. We need more members, more colleagues to join us and make us a stronger and worldwide spread Society.

The covid-19 era also saw an enormous flooding of publications on the topic, most of them of dubious quality. The biomedical community lost time performing “clinical trials” that lacked proper controls and methodology, producing data that, in many cases, was not usable. In other cases, data was not properly obtained and interpreted, creating papers that later had to be withdrawn. And more importantly, science is dangerously mixing with politics, and often they are in opposite sides. This leads to an anti-science momentum that is dangerous to the world. Science and technology play an important role in the improvement of our life quality of the centuries. Turning back the clock and rejecting science and technology is a very dangerous game of unpredictable consequences. 

Covid-19 has also changed the way scientific meetings are organized. Because of this, from September 20-30, 2020, we will have our “ESCI Virtual Meeting - covid19 edition”, that replaces the presential meeting, that we hope to organize in June 2021 in Bari, Italy. For this virtual meeting, we have invited ALL abstract presenters to confirm if they still want to present their work, this type as short or flash webinars in this virtual meeting, combined with plenary talks focusing on covid-19. Everything will be organized as recorded webinars, so participants can go back and watch again, posting questions to the speakers to be answered later. We will combine this with addresses from the ESCI Presidency, the European Journal of Clinical Investigation (EJCI) editor in chief and the local organizer of the next ESCI meeting in Bari. We will also include a couple webinars for young scientists. Two good news: the event is free, only requiring previous registration, and the confirmed abstracts will still be published in a special edition of the EJCI. This special edition will be available online, and, as always, will have a DOI.

As always, please inform us of initiatives that you would like to see implemented, or please send materials that you think are of interest to be included in our newsletter. Consider ESCI a place to discuss science at multiple levels, in which fundamental scientists can look beyond their benches and biological models towards a clinical application, and in which clinicians can look for fundamental biological explanations for disease and treatments. 

We wish you good health, stay protected and protect others, and let us make good science together.

Best regards 


Paulo J. Oliveira, Ph.D. 
ESCI President


Results of the new editorial board of EJCI


It is a great pleasure to share the first 6 months results of the new editorial board of EJCI. We are not there but the data regarding handling of the submissions are very encouraging.

We have managed to cut the handling time with around 50% as compared with 2019. So, one of the goals of the new team to decrease the handling time of the submissions has been achieved. As editor in chief I want to congratulate all members of the editorial board and reviewers for their hard work. I hope that we could continue this tremendous achievement for a very long time. The fast handling of submissions will hopefully attract more and better quality manuscripts, which in turn can help to improve the quality of the journal.  What also might help the journal is the publication of special issues. We have finished the first special issue on covid-19 that will be published this month. I want to thank all the contributors  to this excellent piece of work and in particular Jakub Regieli, councillor of ESCI, and Marcel Twickler, section editor EJCI, for their great commitment as guest editors. It is very encouraging that the impact factor of EJCI increased from 2.78 to 3.48.  The ranking is 34 out of 165 journals, so in Q1 in the category “MEDICINE, GENERAL & INTERNAL”. I will do my utmost best to further improve the quality and impact factor of EJCI in the coming years. For this purpose I need your help to strengthen the board of section editors in the following fields of expertise: epidemiology, genetics, pulmonary disease and neurology.

Please help me to find active section editors in these fields. For further improvement of the handling time of the submissions, we also need dedicated reviewers. Please let us know if you want to join the journal by sending an email to the editorial office: ejcioffice@esci.eu.com. Please do not forget to visit the website of EJCI: https://onlinelibrary.wiley.com/journal/13652362


On behave of the editorial board, 

Hendrik Nathoe, editor in chief.

ESCI Virtual Meeting 2020 | Save the Date

Benefits of being an ESCI member:

•      Unique community of fundamental and clinical researchers

•      Free subscription to the European Journal of Clinical Investigation (EJCI)

•      15% discount on books by Wiley

•      Discount on the ESCI Annual Scientific Meeting registration

•      Access to future exclusive contents

•      Pay a low individual subscription (€ 25/year). 


The European Society for Clinical Investigation sponsors the following awards:
 

•    Best Clinical Research Article published at the EJCI

•    Best Basic Research Article published at the EJCI

•    Young Investigator Award

•    Bio Art Award

•    Poster Awards

•    Travel Awards to attend the Annual Meeting

You can apply for ESCI membership by using the application form on our website: www.esci.eu.com

Please consider becoming a member of the European Society of Clinical
Investigation. Next Anual Meetings in Bari, Italy (2021), Prague,
Czech Republic (2022) and Warsaw, Poland (2023).
Facebook
Twitter
Website
Email
Copyright © 2020 European Society for Clinical Investigation, All rights reserved.


Want to change how you receive these emails?
You can
update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp


Questions or remarks? Mail us at: esci@umcutrecht.nl